ELITechGroup Clinical Systems is pleased to announce the introduction of another new reagent, Lactate, to the growing range of reagents for the Selectra Pro and Mach systems. Lactate is a metabolite of glucose, produced during conditions of insufficient oxygen supply (e.g. rapid exercise). Most Lactate is produced by skeletal muscle and released into the circulation where it is metabolized in the liver (60%) and Kidneys (30%) back to glucose. Lactate can accumulate due to increased production, decreased utilization, or both, resulting in Lactic Acidosis Causes of lactic acidosis are usually classified as Type A: Poor Tissue Oxygen Delivery causing severe hypoxia and anemia, or Type B: No evidence of Hypoxia causing sepsis and severe liver disease.1
The ELITechGroup Lactate Reagent utilizes Lactate Oxidase (LO), so is inherently more stable compared to Lactate reagents based on LDH/NAD providing significantly better onboard reagent & calibration stability. The ELITechGroup Lactate Reagent is an economical option as a liquid-stable, ready-to-use reagent with no special calibrators or controls required. Performance is validated on the Selectra Mach5 and Selectra Pro systems providing confidence in the reported results. Further advantages, the ideal shelf life, and optimized packaging make the ELITechGroup Lactate reagent also an economical option for low-volume testing.
Availability may be subject to regulatory requirements. Please contact your local representative or email sales.ecsnl@elitechgroup.com for information on the availability of these products in your area.
- Evaluating the Possibility of Translating Technological Advances in Non-Invasive Continuous Lactate Monitoring into Critical Care Robert D. Crapnell et. al published on line https://dx.doi.org/10.3390%2Fs21030879
“
